Raymond James Financial
BMRA icon

Raymond James Financial’s Biomerica BMRA Stock Holding History

Raymond James Financial’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,880
Closed -$5.94K – 5187
2025
Q2 		$5.94K Sell
1,880
-1
-0.1% -$4 ﹤0.01% 6113
2025
Q1 		$8.53K Hold
1,881
– – ﹤0.01% 4787
2024
Q4 		$4.52K Buy
+1,881
New +$4.96K ﹤0.01% 4787

Other funds holding BMRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Raymond James Financial's BMRA Position: Q3 2025 in Review

Raymond James Financial sold out of Biomerica (BMRA) in Q3 2025, closing a stake of 1,880 shares — an estimated $5.94K sold.

Raymond James Financial first reported a position in BMRA in Q4 2024 and held it in 3 quarters. The position peaked at $8.53K in Q1 2025. 17 funds tracked by Wall St. Rank hold BMRA as of Q3 2025.

  • Raymond James Financial reported no remaining Biomerica position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 1,880 Biomerica shares in Q3 2025, an estimated $5.94K.
  • Raymond James Financial first reported a position in Biomerica in Q4 2024 and held it in 3 quarters.
  • Raymond James Financial's Biomerica position peaked at $8.53K in Q1 2025.
  • 17 funds tracked by Wall St. Rank held Biomerica as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.